- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
LIGAND PHARMACEUTICALS INCORPORATED
(NASDAQ:LGND)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2008 | Jun 30, 2008 | Mar 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 71,112 | 29,177 | 59,543 | 76,812 |
| Restricted Cash | — | — | — | — |
| Marketable Securities | — | 55,819 | 30,685 | 17,596 |
| Accounts Receivable | — | — | — | — |
| Loans Receivable | — | — | — | — |
| Other Receivable | — | — | 10,416 | — |
| Receivables | — | — | 10,416 | — |
| Raw Materials | — | — | — | — |
| Work in Progress | — | — | — | — |
| Purchased Components | — | — | — | — |
| Finished Goods | — | — | — | — |
| Other Inventories | — | — | — | — |
| Inventories Adjustments and Allowances | — | — | — | — |
| Inventories | — | — | — | — |
| Prepaid Expenses | — | — | 1,252 | — |
| Current Deferred Income Taxes | — | — | — | — |
| Other Current Assets | 14,853 | 11,116 | 3 | 15,535 |
| Total Current Assets | 85,965 | 96,112 | 101,899 | 109,943 |
| Land and Improvements | — | — | — | — |
| Building and Improvements | — | — | — | — |
| Machinery Furniture and Equipment | — | 37,090 | — | 40,577 |
| Construction in Progress | — | — | — | — |
| Other Fixed Assets | — | — | 36,964 | — |
| Total Fixed Assets | — | 37,090 | 36,964 | 40,577 |
| Gross Fixed Assets | 1,687 | 37,090 | 36,964 | 40,577 |
| Accumulated Depreciation and Depletion | — | 35,066 | 34,873 | 37,712 |
| Net Fixed Assets | 1,687 | 2,024 | 2,091 | 2,865 |
| Intangibles | — | — | — | — |
| Cost in Excess | — | — | — | — |
| Non Current Deferred Income Taxes | — | — | — | — |
| Other Non Current Assets | 59,539 | 61,887 | 62,275 | 60,470 |
| Total Non Current Assets | 61,226 | 63,911 | 64,366 | 63,335 |
| Total Assets | 147,191 | 160,023 | 166,265 | 173,278 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 38,197 | 10,290 | 10,760 | 12,682 |
| Notes Payable | 716 | — | — | — |
| Short Term Debt | — | 978 | 1,238 | 1,528 |
| Accrued Expenses | — | — | — | — |
| Accrued Liabilities | — | 22,698 | 21,698 | 24,327 |
| Deferred Revenues | — | 1,964 | 1,964 | 1,964 |
| Current Deferred Income Tax Liabilities | — | — | — | — |
| Other Current Liabilities | 12,788 | 8,682 | 8,651 | 10,467 |
| Total Current Liabilities | 51,701 | 44,612 | 44,311 | 50,968 |
| Non Current Liabilities | ||||
| Long Term Debt | — | 266 | 403 | 627 |
| Capital Lease Obligations | — | — | — | — |
| Deferred Income Tax Liabilities | — | — | — | — |
| Other Non Current Liabilities | 81,191 | 96,124 | 97,017 | 92,568 |
| Minority Interest Liabilities | — | — | — | — |
| Preferred Securities of Subsidiary Trust Liabilities | — | — | — | — |
| Preferred Equity Outside Stock Equity | — | — | — | — |
| Total Non Current Liabilities | 132,892 | 141,002 | 141,731 | 144,163 |
| Total Liabilities | 81,191 | 96,390 | 97,420 | 93,195 |
| Shareholders' Equity | ||||
| Preferred Stock Equity | — | — | — | — |
| Common Stock Equity | 1,954 | 19,021 | 24,534 | 29,115 |
| Common Par | — | 101 | 101 | 101 |
| Additional Paid in Capital | — | 652,956 | 652,055 | 651,038 |
| Cumulative Translation Adjustment | — | — | — | — |
| Retained Earnings | — | -591,874 | -585,445 | -581,512 |
| Treasury Stock | — | -42,134 | -42,134 | -40,521 |
| Other Equity Adjustments | — | -28 | -43 | 9 |
| Total Capitalization | 1,954 | 19,287 | 24,937 | 29,742 |
| Cash Flow | — | -2,847 | 4,942 | 284,303 |
| Working Capital | 34,264 | 51,500 | 57,588 | 58,975 |
| Free Cash Flow | — | -5,697 | -1,537 | -40,585 |
| Invested Capital | 1,954 | 19,287 | 24,937 | 29,742 |
| Total Equity | 1,954 | 19,021 | 24,534 | 29,115 |
| Total Liabilities and Stock Equity | 134,846 | 160,023 | 166,265 | 173,278 |